Breaking News Instant updates and real-time market news.

2020-05-01 13:10:55 AMZN Amazon.com $2,282.00 / -185.26 (-7.51%) , FDX FedEx $119.05 / -7.93 (-6.25%) … 13:10 05/01/20 05/01 13:10 05/01/20 13:10	Amazon, Walmart, Target workers call in sick in act of protest, Verge says Workers from Amazon (AMZN), Whole Foods, Instacart, FedEx (FDX), Target (TGT), and Walmart (WMT) have banded together for a series of work stoppages to protest conditions and equipment in the face of the ongoing COVID-19 pandemic, The Verge's Russell Brandom reports. The actions have been organized by a set of groups within the various companies, but have been timed to coincide with International Workers' Day, Brandom says, noting that the groups are encouraging customers to boycott the stores and services during the day. The protesting workers are calling for better practices and equipment to protect frontline staff from contracting the coronavirus at work, the author notes. Reference Link AMZN Amazon.com $2,282.00 / -185.26 (-7.51%) FDX FedEx $119.05 / -7.93 (-6.25%) TGT Target $106.98 / -2.88 (-2.62%) WMT Walmart $122.35 / +0.79 (+0.65%)	19 May 27 May 14 Sep
AMZN FDX TGT WMT AMZN Amazon.com $2,282.00 / -185.26 (-7.51%) 05/01/20 JPMorgan Amazon.com price target raised to $3,000 from $2,525 at JPMorgan 05/01/20 Raymond James Amazon.com price target raised to $2,525 from $2,400 at Raymond James 05/01/20 BMO Capital Amazon.com price target raised to $2,850 from $2,650 at BMO Capital 05/01/20 Deutsche Bank Amazon.com price target raised to $2,750 from $2,300 at Deutsche Bank FDX FedEx $119.05 / -7.93 (-6.25%) 04/17/20 Fly Intel: Top five analyst downgrades 04/17/20 Barclays FedEx downgraded to Equal Weight with $135 price target at Barclays 04/17/20 Barclays FedEx downgraded to Equal Weight from Overweight at Barclays 04/13/20 Fly Intel: Top five analyst upgrades TGT Target $106.98 / -2.88 (-2.62%) 04/27/20 Oppenheimer Amazon.com price target raised to $2,700 from $2,400 at Oppenheimer 04/24/20 Nomura Target price target lowered to $121 from $131 at Nomura Instinet 04/23/20 Baird Baird cuts Target EPS view on sales mix shift, inventory write-downs 04/15/20 Fly Intel: Top five analyst upgrades WMT Walmart $122.35 / +0.79 (+0.65%) 04/29/20 Fly Intel: Top five analyst downgrades 04/29/20 Cleveland Research Walmart U.S. comps continue to look strong, says Cleveland Research 04/29/20 Gordon Haskett Walmart downgraded to Accumulate on valuation at Gordon Haskett 04/29/20 Gordon Haskett Walmart downgraded to Accumulate from Buy at Gordon Haskett

2020-05-01 13:10:55

AMZN

Amazon.com

$2,282.00 / -185.26 (-7.51%)

, FDX

FedEx

$119.05 / -7.93 (-6.25%)

… 13:10

05/01/20

05/01

13:10

05/01/20

13:10

Amazon, Walmart, Target workers call in sick in act of protest, Verge says

Workers from Amazon (AMZN), Whole Foods, Instacart, FedEx (FDX), Target (TGT), and Walmart (WMT) have banded together for a series of work stoppages to protest conditions and equipment in the face of the ongoing COVID-19 pandemic, The Verge's Russell Brandom reports. The actions have been organized by a set of groups within the various companies, but have been timed to coincide with International Workers' Day, Brandom says, noting that the groups are encouraging customers to boycott the stores and services during the day. The protesting workers are calling for better practices and equipment to protect frontline staff from contracting the coronavirus at work, the author notes. Reference Link

AMZN

Amazon.com

$2,282.00 / -185.26 (-7.51%)

FDX

FedEx

$119.05 / -7.93 (-6.25%)

TGT

Target

$106.98 / -2.88 (-2.62%)

WMT

Walmart

$122.35 / +0.79 (+0.65%)

19
May
27
May
14
Sep

AMZN
FDX
TGT
WMT

AMZN Amazon.com

$2,282.00 / -185.26 (-7.51%)

05/01/20 JPMorgan: Amazon.com price target raised to $3,000 from $2,525 at JPMorgan

05/01/20 Raymond James: Amazon.com price target raised to $2,525 from $2,400 at Raymond James

05/01/20 BMO Capital: Amazon.com price target raised to $2,850 from $2,650 at BMO Capital

05/01/20 Deutsche Bank: Amazon.com price target raised to $2,750 from $2,300 at Deutsche Bank

FDX FedEx

$119.05 / -7.93 (-6.25%)

04/17/20: Fly Intel: Top five analyst downgrades

04/17/20 Barclays: FedEx downgraded to Equal Weight with $135 price target at Barclays

04/17/20 Barclays: FedEx downgraded to Equal Weight from Overweight at Barclays

04/13/20: Fly Intel: Top five analyst upgrades

TGT Target

$106.98 / -2.88 (-2.62%)

04/27/20 Oppenheimer: Amazon.com price target raised to $2,700 from $2,400 at Oppenheimer

04/24/20 Nomura: Target price target lowered to $121 from $131 at Nomura Instinet

04/23/20 Baird: Baird cuts Target EPS view on sales mix shift, inventory write-downs

04/15/20: Fly Intel: Top five analyst upgrades

WMT Walmart

$122.35 / +0.79 (+0.65%)

04/29/20: Fly Intel: Top five analyst downgrades

04/29/20 Cleveland Research: Walmart U.S. comps continue to look strong, says Cleveland Research

04/29/20 Gordon Haskett: Walmart downgraded to Accumulate on valuation at Gordon Haskett

04/29/20 Gordon Haskett: Walmart downgraded to Accumulate from Buy at Gordon Haskett

TODAY'S FREE FLY STORIES

Recommendations	Inter Pipeline price target raised to C$18 from C$17.50 at Scotiabank » 10:34 04/23/21 04/23 10:34 04/23/21 10:34 IPPLF Inter Pipeline $14.50 / +0.2918 (+2.05%) Scotiabank analyst Robert… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research IPPLF Inter Pipeline $14.50 / +0.2918 (+2.05%) 03/11/21 Brookfield Infrastructure comments on Inter Pipeline directors' circular IPPLF Inter Pipeline $14.50 / +0.2918 (+2.05%) 07:39 Today Stifel Inter Pipeline downgraded to Hold at Stifel on strategic review uncertainty 04/22/21 Stifel Inter Pipeline downgraded to Hold from Buy at Stifel 04/06/21 Stifel Inter Pipeline price target raised to C$20.50 from C$20 at Stifel 02/24/21 National Bank Inter Pipeline price target raised to C$18 from C$15 at National Bank
Recommendations	CGI Inc. price target raised to C$112 from C$106 at Scotiabank » 10:34 04/23/21 04/23 10:34 04/23/21 10:34 GIB CGI Inc. $85.50 / -0.02 (-0.02%) Scotiabank analyst Paul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events GIB CGI Inc. $85.50 / -0.02 (-0.02%) 03/30/21 CGI Inc. selected for Federal Reserve Bank's FedNow service pilot 03/23/21 CGI creates 600 jobs at Lafayette delivery center, expects to reach 800 by 2023 03/11/21 CGI Inc. awarded contract by Bavarian State Ministry of Justice 02/26/21 CGI Inc. announces IT delivery center in Knoxville, Tennessee GIB CGI Inc. $85.50 / -0.02 (-0.02%) 04/12/21 Societe Generale CGI Inc. upgraded to Hold from Sell at Societe Generale 03/23/21 Desjardins CGI Inc. resumed with a Buy at Desjardins 03/04/21 Edward Jones CGI Inc. upgraded to Buy from Hold at Edward Jones 02/01/21 Barclays CGI Inc. price target raised to $89 from $80 at Barclays GIB CGI Inc. $85.50 / -0.02 (-0.02%) 01/27/21 CGI Inc. reports Q1 ex-items EPS C$1.33 vs. C$1.23 last year 11/11/20 CGI Inc. reports Q4 EPS C$1.22, vs. C$1.21 last year 04/28/21 CGI Inc. - GIB
Syndicate	Rain Therapeutics indicated to open at $27, IPO priced at $17 » 10:33 04/23/21 04/23 10:33 04/23/21 10:33 RAIN Rain Therapeutics / + Rain Therapeutics (RAIN)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Syndicate 23 Apr
Syndicate	Latham Group indicated to open at $22, IPO priced at $19 » 10:32 04/23/21 04/23 10:32 04/23/21 10:32 SWIM Latham Group / + Latham Group (SWIM)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Syndicate On The Fly 23 Apr SWIM Latham Group / + 04/17/21 Opening Day: Coinbase soars in market debut 04/10/21 Opening Day: Phone maker UTime soars in public debut 04/03/21 Opening Day: Softbank-backed Compass raises $450M in IPO
Options	Bristol Myers Squibb call volume above normal and directionally bullish » 10:25 04/23/21 04/23 10:25 04/23/21 10:25 BMY Bristol-Myers $66.89 / +0.57 (+0.86%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BMY Bristol-Myers $66.89 / +0.57 (+0.86%) 10:03 Today Bristol-Myers says Phase 3 trials of deucravacitinib met co-primary endpoints 06:54 Today Bristol-Myers announces EMA's CHMP recommends approval of Onureg in Europe 06:47 Today Bristol-Myers announces EMA's CHMP recommends approval of Opdivo 04/16/21 Bristol-Myers confirms FDA approves Opdivo combo for gastric cancer BMY Bristol-Myers $66.89 / +0.57 (+0.86%) 04/21/21 Citi Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data 04/21/21 Citi Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy 04/13/21 Truist Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility 04/13/21 Truist Bristol-Myers upgraded to Buy from Hold at Truist BMY Bristol-Myers $66.89 / +0.57 (+0.86%) 03/04/21 Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c) 02/24/21 CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M 02/04/21 Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45 02/04/21 Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41 BMY Bristol-Myers $66.89 / +0.57 (+0.86%) 04/01/21 Accidental disclosure show Bristol-Myers, I.R.S. $1B tax fight, NY Times reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says BMY Bristol-Myers $66.89 / +0.57 (+0.86%) 04/13/21 FedEx, Booking Holdings upgrades among today's top calls on Wall Street 03/29/21 Fly Intel: Pre-market Movers 02/09/21 Fly Intel: Pre-market Movers 12/26/20 Week in review: How Trump's policies moved stocks 11:00 Today Pharmaceuticals 12:00 Today Biotechnology 04/29/21 Bristol-Myers - BMY 04/29/21 Oncologic Drugs Advisory Committee Virtual Meeting 05/20/21 PDUFA Date for CM-577 - Opdivo 05/25/21 PDUFA Date for CM-649 Opdivo+ Yervoy or Chemo 05/30/21 PDUFA Date for Zeposia (Ozanimod) 01/28/22 PDUFA Date for Mavacamten 05/04/21 Bristol Myers Squibb Co BMY Bristol-Myers $66.89 / +0.57 (+0.86%) 04/07/21 Unusually active option classes on open April 7th 01/20/21 Unusually active option classes on open January 20th 01/11/21 Unusually active option classes on open January 11th 01/05/21 Bristol Myers Squibb call volume above normal and directionally bullish

Conference/Events	Cowen pharmaceuticals analysts to hold analyst/industry conference call » 10:25 04/23/21 04/23 10:25 04/23/21 10:25 BMY Bristol-Myers $66.89 / +0.57 (+0.86%) Pharmaceuticals Analysts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BMY Bristol-Myers $66.89 / +0.57 (+0.86%) 10:03 Today Bristol-Myers says Phase 3 trials of deucravacitinib met co-primary endpoints 06:54 Today Bristol-Myers announces EMA's CHMP recommends approval of Onureg in Europe 06:47 Today Bristol-Myers announces EMA's CHMP recommends approval of Opdivo 04/16/21 Bristol-Myers confirms FDA approves Opdivo combo for gastric cancer BMY Bristol-Myers $66.89 / +0.57 (+0.86%) 04/21/21 Citi Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data 04/21/21 Citi Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy 04/13/21 Truist Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility 04/13/21 Truist Bristol-Myers upgraded to Buy from Hold at Truist BMY Bristol-Myers $66.89 / +0.57 (+0.86%) 03/04/21 Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c) 02/24/21 CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M 02/04/21 Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45 02/04/21 Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41 BMY Bristol-Myers $66.89 / +0.57 (+0.86%) 04/01/21 Accidental disclosure show Bristol-Myers, I.R.S. $1B tax fight, NY Times reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says BMY Bristol-Myers $66.89 / +0.57 (+0.86%) 04/13/21 FedEx, Booking Holdings upgrades among today's top calls on Wall Street 03/29/21 Fly Intel: Pre-market Movers 02/09/21 Fly Intel: Pre-market Movers 12/26/20 Week in review: How Trump's policies moved stocks 11:00 Today Pharmaceuticals 12:00 Today Biotechnology 04/29/21 Bristol-Myers - BMY 04/29/21 Oncologic Drugs Advisory Committee Virtual Meeting 05/20/21 PDUFA Date for CM-577 - Opdivo 05/25/21 PDUFA Date for CM-649 Opdivo+ Yervoy or Chemo 05/30/21 PDUFA Date for Zeposia (Ozanimod) 01/28/22 PDUFA Date for Mavacamten 05/04/21 Bristol Myers Squibb Co BMY Bristol-Myers $66.89 / +0.57 (+0.86%) 04/07/21 Unusually active option classes on open April 7th 01/20/21 Unusually active option classes on open January 20th 01/11/21 Unusually active option classes on open January 11th 01/05/21 Bristol Myers Squibb call volume above normal and directionally bullish
Conference/Events	Cantor Fitzgerald biopharma analysts hold an analyst/industry conference call » 10:25 04/23/21 04/23 10:25 04/23/21 10:25 Large Cap & Biopharma… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	UBS technology analyst to hold an analyst/industry conference call » 10:25 04/23/21 04/23 10:25 04/23/21 10:25 Technology Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	Truist digital advertising analysts to hold analyst/industry conference call » 10:25 04/23/21 04/23 10:25 04/23/21 10:25 Digital Ad Analysts,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Allegiance Bancshares approves stock repurchase authorization up to 1M shares » 10:24 04/23/21 04/23 10:24 04/23/21 10:24 ABTX Allegiance Bancshares $39.02 / + (+0.00%) On April 22, 2021, the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ABTX Allegiance Bancshares $39.02 / + (+0.00%) 10:23 Today Allegiance Bancshares appoints Raimundo Riojas to board of directors 01/28/21 Allegiance Bancshares raises quarterly dividend 20% to 12c per share ABTX Allegiance Bancshares $39.02 / + (+0.00%) 10/02/20 Janney Montgomery Scott Allegiance Bancshares initiated with a Neutral at Janney Montgomery Scott ABTX Allegiance Bancshares $39.02 / + (+0.00%) 01/28/21 Allegiance Bancshares reports Q4 EPS 77c, consensus 71c 10/29/20 Allegiance Bancshares reports Q3 EPS 79c, consensus 52c 04/29/21 Allegiance Bancshares - ABTX

Recommendations	WeCommerce price target lowered to C$23 from C$26 at TD Securities » 10:23 04/23/21 04/23 10:23 04/23/21 10:23 WECMF WeCommerce $14.79 / +0.4312 (+3.00%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Allegiance Bancshares appoints Raimundo Riojas to board of directors » 10:23 04/23/21 04/23 10:23 04/23/21 10:23 ABTX Allegiance Bancshares $39.02 / + (+0.00%) Allegiance Bancshares… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ABTX Allegiance Bancshares $39.02 / + (+0.00%) 01/28/21 Allegiance Bancshares raises quarterly dividend 20% to 12c per share ABTX Allegiance Bancshares $39.02 / + (+0.00%) 10/02/20 Janney Montgomery Scott Allegiance Bancshares initiated with a Neutral at Janney Montgomery Scott ABTX Allegiance Bancshares $39.02 / + (+0.00%) 01/28/21 Allegiance Bancshares reports Q4 EPS 77c, consensus 71c 10/29/20 Allegiance Bancshares reports Q3 EPS 79c, consensus 52c 04/29/21 Allegiance Bancshares - ABTX
Recommendations	Intact Financial price target raised to C$185 from C$175 at TD Securities » 10:22 04/23/21 04/23 10:22 04/23/21 10:22 IFCZF Intact Financial $130.32 / -0.03 (-0.02%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research IFCZF Intact Financial $130.32 / -0.03 (-0.02%) 02/12/21 Desjardins Intact Financial price target raised to C$175 from C$170 at Desjardins 02/10/21 National Bank Intact Financial price target raised to C$200 from C$192 at National Bank 02/10/21 TD Securities Intact Financial price target raised to C$175 from C$170 at TD Securities 12/08/20 Scotiabank Intact Financial price target raised to C$175 from C$166 at Scotiabank
Hot Stocks	GlaxoSmithKline reports European Commission approves Jemperli » 10:22 04/23/21 04/23 10:22 04/23/21 10:22 GSK GlaxoSmithKline $37.65 / -0.03 (-0.08%) GlaxoSmithKline announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSK GlaxoSmithKline $37.65 / -0.03 (-0.08%) 06:41 Today Roche announces FDA approval of VENTANA MMR RxDx panel 04/22/21 GlaxoSmithKline announces FDA approval of JEMPERLI 04/22/21 FDA approves Jemperli for dMMR endometrial cancer 04/22/21 GlaxoSmithKline confirms FDA approval for Jemperli GSK GlaxoSmithKline $37.65 / -0.03 (-0.08%) 04/20/21 Morgan Stanley GlaxoSmithKline price target lowered to 1,550 GBp at Morgan Stanley 04/20/21 UBS GlaxoSmithKline price target raised to 1,360 GBp from 1,320 GBp at UBS 04/20/21 Citi GlaxoSmithKline collaboration with Merck would be 'win-win,' says Citi 03/23/21 Fly Intel: Top five analyst downgrades GSK GlaxoSmithKline $37.65 / -0.03 (-0.08%) 02/03/21 GlaxoSmithKline reports Q4 adjusted EPS 23.3p vs. 24.8p a year ago 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago GSK GlaxoSmithKline $37.65 / -0.03 (-0.08%) 04/15/21 Activist Elliott builds 'multibillion-pound' stake in GlaxoSmithKline, FT says 02/09/21 Teva wins new hearing on $235M GSK patent verdict, Bloomberg reports 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports GSK GlaxoSmithKline $37.65 / -0.03 (-0.08%) 03/11/21 Fly Intel: Wall Street's top stories for Thursday 03/11/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 05/24/21 Global Healthcare Virtual Conference 2021 04/28/21 GlaxoSmithKline - GSK GSK GlaxoSmithKline $37.65 / -0.03 (-0.08%) 04/15/21 Unusually active option classes on open April 15th
Recommendations	Walmart+ members may have declined to 11.1M in March, says Cowen » 10:21 04/23/21 04/23 10:21 04/23/21 10:21 WMT Walmart $139.75 / +0.08 (+0.06%) Cowen analyst Oliver Chen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options WMT Walmart $139.75 / +0.08 (+0.06%) 04/20/21 Velodyne Lidar signs multi-year sales agreement with Gatik 04/20/21 U.K.'s CMA: Bellis' purchase of Asda raises some competition concerns 04/19/21 Walmart adds the BinaxNOW COVID-19 Antigen Self Test 04/19/21 Abbott begins shipping BinaxNOW COVID-19 Ag Self Test to retailers WMT Walmart $139.75 / +0.08 (+0.06%) 04/06/21 Morgan Stanley Walmart+ membership 'seems to have stagnated,' says Morgan Stanley 03/16/21 MKM Partners Walmart price target lowered to $141 from $154 at MKM Partners 02/23/21 Evercore ISI Walmart accelerating change with investments, says Evercore ISI 02/19/21 Morgan Stanley Walmart terminal value rising with investments, says Morgan Stanley WMT Walmart $139.75 / +0.08 (+0.06%) 02/18/21 Walmart reports Q4 adjusted EPS $1.39, consensus $1.51 02/17/21 Notable companies reporting before tomorrow's open 02/17/21 Notable companies reporting before tomorrow's open 11/17/20 Walmart reports Q3 adjusted EPS $1.34, consensus $1.18 WMT Walmart $139.75 / +0.08 (+0.06%) 04/21/21 Walmart phasing out automated pickup towers, WSJ reports 04/13/21 Walmart compliance chief leaving company, WSJ reports 04/13/21 Walmart chief ethics and compliance officer leaving company, WSJ says 04/09/21 McDonald's closing 'hundreds' of restaurants inside Walmart, WSJ reports WMT Walmart $139.75 / +0.08 (+0.06%) 04/19/21 Charged: Walmart invests in GM-backed self-driving company Cruise 04/19/21 Vizio rises as Wall Street analysts roll out bullish coverage 03/17/21 Street Fight: Analysts diverge on Plug following financial restatement news 03/10/21 Fly Intel: What to watch in Oracle's earnings report 06/02/21 Wal-Mart Stores, Inc. WMT Walmart $139.75 / +0.08 (+0.06%) 04/20/21 Wal-Mart call volume above normal and directionally bullish 04/06/21 Wal-Mart call volume above normal and directionally bullish 04/05/21 Unusually active option classes on open April 5th 03/29/21 Unusually active option classes on open March 29th

Recommendations	Well Health Technologies price target raised to C$10.50 from C$10 at TD Securities » 10:19 04/23/21 04/23 10:19 04/23/21 10:19 WLYYF Well Health Technologies $5.50 / -0.1591 (-2.81%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research WLYYF Well Health Technologies $5.50 / -0.1591 (-2.81%) 03/19/21 TD Securities Well Health price target lowered to C$10 from C$11 at TD Securities 03/10/21 Desjardins Well Health Technologies upgraded to Buy from Hold at Desjardins 02/18/21 Stifel Well Health Technologies price target raised to C$13.50 from C$10 at Stifel 02/10/21 Desjardins Well Health Technologies downgraded to Hold from Buy at Desjardins
Recommendations	Superior Plus price target raised to C$16.50 from C$15.50 at TD Securities » 10:19 04/23/21 04/23 10:19 04/23/21 10:19 SUUIF Superior Plus $11.79 / -0.0109 (-0.09%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SUUIF Superior Plus $11.79 / -0.0109 (-0.09%) 05:00 Today Industrial Alliance Superior Plus downgraded to Hold from Buy at Industrial Alliance 02/22/21 BMO Capital Superior Plus price target raised to C$12.50 from C$12 at BMO Capital 02/19/21 TD Securities Superior Plus price target raised to C$15.50 from C$14.50 at TD Securities 02/19/21 Scotiabank Superior Plus price target raised to C$15 from C$13 at Scotiabank
Technical Analysis	NASDAQ market internals summary » 10:17 04/23/21 04/23 10:17 04/23/21 10:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 04/22/21 NASDAQ market internals summary 04/22/21 NASDAQ market internals summary 04/22/21 NASDAQ market internals summary 04/22/21 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 10:16 04/23/21 04/23 10:16 04/23/21 10:16 $NYE NYSE Market Internals / + Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 04/22/21 NYSE market internals summary 04/22/21 NYSE market internals summary 04/22/21 NYSE market internals summary 04/22/21 NYSE market internals summary
Hot Stocks	Sanofi announces presentation of Dupixent analyses on safety, efficacy » 10:15 04/23/21 04/23 10:15 04/23/21 10:15 SNY Sanofi $51.48 / -0.57 (-1.10%) New analyses from… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events SNY Sanofi $51.48 / -0.57 (-1.10%) 10:04 Today Regeneron announces new analyses on Dupixent in patients with Atopic Dermatitis 04/22/21 MediciNova receives two milestone payments from Sanofi subsidiary for $4M 04/20/21 Kazia Therapeutics expands pipeline to include EVT801 04/19/21 Sanofi says EC approves second indication of Sarclisa for relapsed MM SNY Sanofi $51.48 / -0.57 (-1.10%) 04/06/21 Barclays Sanofi price target raised to EUR 85 from EUR 80 at Barclays 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list 02/10/21 Morgan Stanley Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley 02/05/21 Piper Sandler Piper reiterates Overweight on Kymera after Sanofi capital markets day SNY Sanofi $51.48 / -0.57 (-1.10%) 02/05/21 Sanofi reports Q4 business EPS EUR 1.22, flat vs. last year 10/29/20 Sanofi reports Q3 business EPS EUR 1.83, up 0.5% from last year SNY Sanofi $51.48 / -0.57 (-1.10%) 03/15/21 BioNTech recruits Novartis, Sanofi to boost vaccine production, WSJ reports 02/15/21 CEO says Sanofi mRNA vaccine won't be ready this year, Bloomberg reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 02/11/21 Amgen loses appeal to revive PCSK9 antibody patent suit, Bloomberg reports SNY Sanofi $51.48 / -0.57 (-1.10%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/26/20 Week in review: How Trump's policies moved stocks 04/28/21 Sanofi - SNY 05/18/21 PDUFA Date for Avalglucosidase Alfa

General news	FX Action: The dollar » 10:15 04/23/21 04/23 10:15 04/23/21 10:15 $ECON Economic Data / + FX Action: The dollar was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><<
General news	U.S. new home sales surged 20.7% to 1,021k in March » 10:15 04/23/21 04/23 10:15 04/23/21 10:15 $ECON Economic Data / + U.S. new home sales… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><<
General news	Treasury Action: yields have jumped up » 10:15 04/23/21 04/23 10:15 04/23/21 10:15 $ECON Economic Data / + Treasury Action: yields… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><<
Hot Stocks	Arena Pharmaceuticals: Etrasimod 2mg group achieved SS in Phase 2b trial » 10:11 04/23/21 04/23 10:11 04/23/21 10:11 ARNA Arena Pharmaceuticals $67.71 / +0.91 (+1.36%) Arena Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly ARNA Arena Pharmaceuticals $67.71 / +0.91 (+1.36%) 03/02/21 Arena Pharmaceuticals slides after IBS trial did not meet primary endpoint 03/02/21 Arena Pharmaceuticals reports topline results from Phase 2b CAPTIVATE trial 02/02/21 Arena Pharmaceuticals completes enrollment of ELEVATE UC 52 trial 12/08/20 Arena Pharmaceuticals achieves target enrollment for Phase 3 ELEVATE UC 52 trial ARNA Arena Pharmaceuticals $67.71 / +0.91 (+1.36%) 04/06/21 Evercore ISI Evercore starts 'compelling' Arena spinoff Longboard at Outperform 03/26/21 H.C. Wainwright Arena Pharmaceuticals price target raised to $120 from $90 at H.C. Wainwright 03/03/21 Cantor Fitzgerald Arena Pharmaceuticals price target lowered to $100 from $106 at Cantor Fitzgerald 03/03/21 JonesTrading Arena Pharmaceuticals price target lowered to $94 from $101 at JonesTrading ARNA Arena Pharmaceuticals $67.71 / +0.91 (+1.36%) 02/23/21 Arena Pharmaceuticals reports Q4 EPS ($2.10), consensus ($1.85) 11/09/20 Arena Pharmaceuticals reports Q3 EPS ($1.69), consensus ($1.87) 28 May ARNA Arena Pharmaceuticals $67.71 / +0.91 (+1.36%) 11/05/20 Governor Cuomo says NY 'ripe' for pot legalization, amNewYork says 11/04/20 Marijuana legalization measures set to pass in five states, Tech Crunch says ARNA Arena Pharmaceuticals $67.71 / +0.91 (+1.36%) 03/02/21 Fly Intel: After-Hours Movers 11/10/20 Fly Intel: Wall Street's top stories for Tuesday 11/10/20 Fly Intel: Wall Street's top stories at midday 11/10/20 Fly Intel: Pre-market Movers
Hot Stocks	Navigator Holdings awarded four handysize timecharter contracts » 10:11 04/23/21 04/23 10:11 04/23/21 10:11 NVGS Navigator Holdings $9.54 / + (+0.00%) Navigator Holdings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings NVGS Navigator Holdings $9.54 / + (+0.00%) 04/12/21 Navigator Holdings, Ultragas ApS to merge fleets, businesses 04/12/21 Navigator Holdings, Ultragas ApS to merge fleets, businesses 12/29/20 Navigator Holdings closes sale of 39.1% equity interest to BW Group 12/15/20 WL Ross & Co. to sell 39.1% interest in Navigator Holdings to BW Group NVGS Navigator Holdings $9.54 / + (+0.00%) 01/29/21 Jefferies Navigator Holdings price target raised to $14 from $12 at Jefferies 01/27/21 Evercore ISI Navigator Holdings downgraded to In Line from Outperform at Evercore ISI 01/27/21 Evercore ISI Navigator Holdings downgraded to In Line from Outperform at Evercore ISI NVGS Navigator Holdings $9.54 / + (+0.00%) 03/18/21 Navigator Holdings reports Q4 preliminary EPS 6c, two estimates 15c 11/12/20 Navigator Holdings reports Q3 EPS 3c, consensus 9c

Events

Earnings calls, analyst events, roadshows and more

GBCI
Today at 11:00

Glacier Bancorp - GBCI Conference Calls
OZK
Today at 11:00

Bank OZK - OZK Conference Calls
AZZ
Today at 11:00

AZZ Inc. - AZZ Conference Calls
EIG
Today at 11:00

Employers Holdings - EIG Conference Calls
NBHC
Today at 11:00

National Bank - NBHC Conference Calls
NGA
Today at 11:00

NORTHERN GENESIS ACQUISITION Firm Sponsored Meetings
SNCA
Today at 11:00

Seneca Biopharma Inc Firm Sponsored Meetings
Today at 11:00

Digital Advertising Industry Meetings
Today at 11:00

Biopharma & Medical Devices Industry Meetings
BMY
Today at 11:00

Pharmaceuticals Industry Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares IFBD X IFBD Infobird IPO Managers: WestPark Capital Priced at: $4.00 6.25M Shares
Tues	DV X DV DoubleVerify IPO Managers: Goldman Sachs & JPMorgan, Barclays, RBC Capital, Truist, William Blair, KeyBanc, Canaccord, JMP Securities, Needham, Loop Capital, Capital One Priced at: $27.00 13.3M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PATH X PATH UiPath IPO Managers: Morgan Stanley & JPMorgan, BofA, Credit Suisse, Barclays, Wells Fargo, SMBC Nikko, BMO Capital, MIZU, KeyBanc, TD Securities, Truist, Cowen, Evercore ISI, Macquarie, Nomura, RBC Capital, Canaccord, DA Davidson, Oppenheimer, Needham Priced at: $56.00 23.89M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SKYT X SKYT SkyWater Technology IPO Managers: Jefferies & Cowen, Piper Sandler Priced at: $14.00 6.96M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TRKA X TRKA Troika Media IPO Managers: Kingswood Priced at: $4.15 5.78M Shares FUTU X FUTU Futu Holdings Secondary Managers: BofA & Haitong Priced at: $130.00 9.5M Shares ZLAB X ZLAB Zai Lab Secondary Managers: JPMorgan, Goldman Sachs, Jefferies, Citi, SVB Leerink & Guggenheim Priced at: $150.00 4.78M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NOTV X NOTV Inotiv Spot Secondary Managers: Colliers Priced at: $17.00 2.647M Shares
Wed	KNBE X KNBE KnowBe4 IPO Managers: Morgan Stanley, Goldman Sachs, BofA & KKR Priced at: $16.00 9.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NPCE X NPCE NeuroPace IPO Managers: JPMorgan & Morgan Stanley, Wells Fargo, SVB Leerink Priced at: $17.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZY X ZY Zymergen IPO Managers: JPMorgan & Goldman Sachs, BofA, UBS, LAZA Priced at: $31.00 16.13M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EOLS X EOLS Evolus Spot Secondary Managers: SVB Leerink, Stifel & Cantor Fitzgerald Priced at: $9.50 9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NBSE X NBSE NeuBase Therapeutics Spot Secondary Managers: RBC Capital, Oppenheimer & Chardan, National Securities Priced at: $5.00 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AGTI X AGTI Agiliti IPO Managers: BofA, Goldman Sachs, Morgan Stanley & BMO Capital, Citi, JEFF< UBSW, KeyBanc, Raymond James, MUFG, SMBC Nikko, MISC, SIEB Priced at: $14.00 26.316M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IMPL X IMPL Impel NeuroPharma IPO Managers: Cowen & Guggenheim, Wedbush Priced at: $15.00 5.33M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RAIN X RAIN Rain Therapeutics IPO Managers: Goldman Sachs, Citi, Piper Sandler & Guggenheim Priced at: $17.00 7.353M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SWIM X SWIM Latham Group IPO Managers: Barclays, BofA, Morgan Stanley & Goldman Sachs, Nomura, William Blair, Baird, KeyBanc, Truist Priced at: $19.00 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TMCI X TMCI Treace Medical IPO Managers: JPMorgan & Morgan Stanley, SVB Leerink, Stifel Priced at: $17.00 11.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDAP X EDAP EDAP TMS Spot Secondary Managers: Piper Sandler Priced at: $6.75 4.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Amazon, Walmart, Target workers call in sick in act of protest, Verge says

TODAY'S FREE FLY STORIES

Get Full Fly Access